Richard Daniell Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Richard Daniell is Exec. VP, European Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 0 shares of TEVA, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2024, when has been sold 98,943 shares (Ordinary Shares) at a price of $17.3 per share, resulting in proceeds of $1,711,713. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Richard Daniell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2024	SELL Open market or private sale	$1,711,713 $17.3 p/Share	98,943 Reduced 100.0%	0 Ordinary Shares
Mar 05 2024	SELL Open market or private sale	$657,464 $13.52 p/Share	48,629 Reduced 32.95%	98,943 Ordinary Shares
Mar 05 2024	BUY Exercise of conversion of derivative security	-	77,802 Added 38.36%	124,996 Ordinary Shares
Mar 04 2024	SELL Open market or private sale	$1,277,465 $13.34 p/Share	95,762 Reduced 57.85%	69,770 Ordinary Shares
Mar 04 2024	BUY Exercise of conversion of derivative security	-	33,512 Added 24.5%	103,282 Ordinary Shares
Mar 03 2024	BUY Exercise of conversion of derivative security	-	62,250 Added 32.04%	132,020 Ordinary Shares
Feb 28 2024	SELL Open market or private sale	$270,258 $13.12 p/Share	20,599 Reduced 22.79%	69,770 Ordinary Shares
Feb 28 2024	BUY Exercise of conversion of derivative security	-	20,599 Added 18.56%	90,369 Ordinary Shares
Mar 07 2023	SELL Open market or private sale	$509,286 $9.43 p/Share	54,007 Reduced 43.63%	69,770 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$178,759 $9.93 p/Share	18,002 Reduced 12.7%	123,777 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	22,576 Added 13.74%	141,779 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	49,433 Added 29.31%	119,203 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$437,652 $9.89 p/Share	44,252 Reduced 38.81%	69,770 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	70,840 Added 43.13%	93,424 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$166,385 $7.37 p/Share	22,576 Reduced 34.33%	43,182 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	22,576 Added 25.56%	65,758 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$272,092 $7.48 p/Share	36,376 Reduced 45.72%	43,182 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	59,278 Added 48.23%	63,638 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$167,668 $8.14 p/Share	20,598 Reduced 50.39%	20,280 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	20,598 Added 33.51%	40,878 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$119,003 $9.06 p/Share	13,135 Reduced 39.31%	20,280 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	13,135 Added 28.22%	33,415 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$79,488 $10.58 p/Share	7,513 Reduced 27.03%	20,280 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	15,920 Added 36.42%	27,793 Ordinary Shares
Mar 03 2021	SELL Open market or private sale	$10,804 $10.88 p/Share	993 Reduced 7.72%	11,873 Ordinary Shares

Richard Daniell

Exec. VP, European Commercial

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account